Press Release Archive

02.21.2017

Pfizer Announces Acceptance of Regulatory Submission for Inotuzumab Ozogamicin by the U.S. Food and Drug Administration

02.17.2017

New Data in Crohn’s Disease Patients Shows Similar Efficacy and Safety Profiles for INFLECTRA® and REMICADE®a

02.16.2017

Pfizer Announces Top-Line Results from the Oral Strategy Trial of XELJANZ® (tofacitinib citrate) Compared to Humira® (adalimumab)

02.08.2017

Pfizer Receives FDA Approval for EUCRISA™ (crisaborole)

02.08.2017

Relationship Expert Teams Up with Pfizer to Address Intimacy and Relationship Issues for People Living with Chronic Diseases

01.31.2017

Edelris Announces Research Collaboration Agreement with Pfizer Inc.

01.31.2017

PFIZER REPORTS FOURTH-QUARTER AND FULL-YEAR 2016 RESULTS

01.27.2017

Pfizer Receives Positive CHMP Opinion in Europe for XELJANZ® (tofacitinib citrate) for the Treatment of Moderate to Severe Active Rheumatoid Arthritis

01.26.2017

Pfizer Announces Positive Top-Line Results from Phase 2 Study of Investigational Clostridium difficile Vaccine for the Prevention of C. difficile Infection

01.19.2017

Milner Therapeutics Institute announces new partnership with US pharmaceutical company Pfizer

01.10.2017

The Scripps Research Institute Signs Collaboration Agreement with Pfizer to Advance DNA-Encoded Library Technology

01.06.2017

Guardant Health to create a new 500-plus-gene liquid biopsy panel with several leading pharmaceutical companies to accelerate clinical trials and drug development